According to a comprehensive report by TechSci Research titled “Metagenomics Sequencing Market – Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028F,” the Global Metagenomics Sequencing Market is expected to witness significant growth during the forecast period of 2024-2028. This growth can be attributed to the research and development activities focused on the development of novel drugs and the increasing demand for advanced sequencing technology across the region. The market is further driven by the growing applications of metagenomics in various fields such as bioremediation, ecological and environmental metagenomics, clinical diagnostics, drug development, and industrial use. Moreover, the adoption of bioinformatics technology in diagnostic procedures and the demand for the discovery of new proteins, including antibiotics, through DNA purification, cloning, and expression from organisms, will further boost the growth of the Global Metagenomics Sequencing Market. Governments worldwide are also providing support for the development of the healthcare industry, including funding for research and development, which is driving the demand for metagenomics sequencing.
activities and collaborations in the pharmaceutical and biotechnology industries.
Browse over XX market data Figures spread through xx Pages and an in-depth TOC on “Global Metagenomics Sequencing Market.” – https://www.techsciresearch.com/report/metagenomics-sequencing-market/15130.html
Challenges and Market Segmentation
However, the cost of metagenomics sequencing, particularly for high-throughput technologies, can be a limiting factor for the growth of the Global Metagenomics Sequencing Market. Additionally, the generation of large amounts of data during metagenomics sequencing poses challenges in terms of analysis and interpretation. Advanced bioinformatics tools and expertise are often required to derive meaningful insights from the data, creating a further challenge and restricting market growth. Furthermore, the lack of standardization in metagenomics sequencing machines and the inherent diversity of microbial communities in environmental samples pose challenges in accurately capturing and sequencing the entire microbial diversity, which may hamper market growth.
Market Segmentation Based on Technology
The Global Metagenomics Sequencing Market can be segmented based on technology into the following categories:
- Shotgun Metagenomic Sequencing
- 16S rRNA Sequencing
- Whole Genome Sequencing & De Novo Assembly
- Meta Transcriptomics
The whole genome sequencing & de novo assembly segment dominated the market in 2022 and is expected to maintain its dominance throughout the forecast period. This can be attributed to technological breakthroughs in genomic sequencing, such as meta proteomics and meta transcriptomics, along with increased research and development spending on genome research for the development of novel drugs and techniques for the treatment of chronic diseases. The segment also benefits from the growing knowledge of metagenomics among healthcare providers. Additionally, investments by firms developing the next generation of genomics and bioinformatics are expected to create lucrative growth opportunities during the forecast period.
Market Segmentation Based on Application
Based on application, the market can be segmented into the following categories:
- Drug Discovery
- Ecological & Environmental Metagenomics
- Clinical Diagnostics
- Biofuel
- Industrial Applications
The drug discovery segment is expected to dominate the market during the forecast period. This can be attributed to the increasing research and development activities on genomic sequencing in the pharmaceutical and biotechnology industries, specifically for novel drug discovery and exploration of antimicrobial activity. Collaboration between market players and academic institutes further supports the growth of this segment.
The Global Metagenomics Sequencing Market is poised for impressive growth, driven by research and development activities, as well as the increasing demand for advanced sequencing technology. However, challenges related to cost, data analysis, standardization, and capturing microbial diversity may restrict market growth. The market segmentation based on technology highlights the dominance of whole genome sequencing & de novo assembly, benefiting from technological breakthroughs and increased research and development spending. Similarly, the drug discovery segment is expected to dominate the market in terms of application, driven by extensive research
Major companies operating in the Global Metagenomics Sequencing Market are:
- BGI Genomics Co Ltd.
- Eurofins Scientific Se.
- Illumina Inc.
- Macrogen Inc.
- Oxford Nanopore Technologies Ltd.
- Pacific Biosciences of California Inc.
- Perkinelmer Inc.
- Qiagen N.V.
- Swift Biosciences Inc.
- Thermo Fisher Scientific Inc.
In December 2021, Oriel Research announced the launched of metagenomics pipeline. It is being used for supporting metagenomics analysis to allow the full synergism between big data used for bioinformatics analytical tools and novel biological platforms, for delivering metagenomics discoveries to patients.
In June 2021, Illumina announced an agreement with the Belgian Genetic Centers to evaluate whole genome sequencing for the diagnosis of patients with intellectual disabilities and developmental disorders.
Pacific Biosciences (PacBio) launched the Sequel II System in 2019. This long-read sequencing platform offers high-accuracy sequencing and longer read lengths, making it valuable for metagenomics studies. The system allows for better assembly of complex microbial genomes and improved characterization of microbial community structures.
In February 2021, PacBio announced that Childrens Mercy Kansas City increased its investment in highly accurate HiFi sequencing with four new Sequel Ile Systems to add to its two existing Sequel Ile Systems.
Customers can also request for 10% free customization on this report.
“North America is expected to dominate in the Global Metagenomics Sequencing Market due to the growing well established healthcare infrastructure along with growing demand for advance sequencing technique for easy detection of diseases across the region. Similarly, growing interest of researchers in the field of meta transcriptomics, metabolomics, and metaproteomic and investments in bioinformatics to promote metagenomics and microbiome is expected to create lucrative growth in the market during the forecast period. Also, growing concern about viral diseases such as hepatitis-B, HIV/AIDS, influenza, diarrhea along with growing research and development for identifying the genes of the viral diseases are expected to drive the growth of the market during the forecast period. Furthermore, growing availability of technologically advanced product and robust sample processing and library preparation assay kits for exploring the genome activity , and the demand for efficient library preparation products will further be expected to create lucrative opportunities for market growth” said Mr. Karan Chechi, Research Director with TechSci Research, a research-based global management consulting firm.
“Metagenomics Sequencing Market – Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028F”
Segmented By Product and Service (Reagents & consumables, Instruments, Services), By Technology (Shotgun metagenomic sequencing, 16S rRNA sequencing, Whole genome sequencing & de novo assembly, Meta transcriptomics), By Application (Drug discovery, Ecological & environmental metagenomics, Clinical diagnostics, Biofuel, Industrial applications), By Region and By Competition”, has evaluated the future growth potential of global Metagenomics Sequencing market and provides statistics & information on market size, structure, and future market growth. The report intends to provide cutting-edge market intelligence and help decision-makers take sound investment decisions. Besides, the report also identifies and analyzes the emerging trends along with essential drivers, challenges, and opportunities in the Global Metagenomics Sequencing market.
Download Sample Report – https://www.techsciresearch.com/sample-report.aspx?cid=15130
Related Reports:
About TechSci Research:
TechSci Research is a research-based management consulting firm providing market research and advisory solutions to its customers worldwide, spanning a range of industries. TechSci Research’s core values are value, integrity and insight. Led by a team of dynamic industry experts, TechSci Research provides its customers with high value market research and advisory services that helps them identify new market opportunities, growth engines and innovative ways to capture the market share. As a result, TechSci’s client leads rather than follow market trends. Not bound by legacy, TechSci’s cutting-edge research model leverages its decades of research knowledge and an increased use of technology as engines of innovation to deliver unique research value. Provided as an alternative to traditional market research, TechSci Research reports do not just deliver data and knowledge rather highlights the insights in a more usable and interactive format for its clients.
Contact
Mr. Ken Mathews
708 Third Avenue,
Manhattan, NY,
New York – 10017
Tel: +1-646-360-1656
Email: sales@techsciresearch.com
Web: https://www.techsciresearch.com